Syntheses and Bioactivities of Targeted and Conformationally Restrained Taxol Analogs

View/ Open
Downloads: 188
Downloads: 104
Downloads: 73
Date
2004-05-10Author
Liu, Changhui
Metadata
Show full item recordAbstract
Taxol (1) was first isolated from the bark of the Pacific yew about 35 years ago by Drs. Wall and Wani. Although its development as an anticancer agent was delayed by numerous reasons, including its scarcity and insolubility, the discovery of its tubulin-assembly activity and other factors motivated oncologists to overcome these problems. It has since become one of the most important current drugs for the treatment of several cancers, including breast and ovarian cancers.
Like almost all anticancer drugs taxol does have some toxic side effects and many tumors also show significant resistance to therapy with taxol. Drug targeting studies aimed at improving its selectivity and efficacy is described. Two targeting methods, the estrogen receptor (ER) directed targeting and colloidal gold (cAu)directed targeting, were used in our research. In this dissertation, a series of estradiol-taxol conjugates (ETCs) were synthesized. They were active in four cytotoxicity assays and tubulin polymerization assay, but less active than taxol. One of them showed the desired selectivity for ER positive cancer cells.
Recently, several studies have attempted to elucidate the bioactive binding conformation of taxol on microtubules. Three models have been proposed for this conformation. The T-taxol conformation was proposed by Dr. Snyder based on electron crystallographic density and molecular modeling. In this dessertation, a series of cyclopropyl-containing taxol analogs and macrocyclic taxol lactones were synthesized. The bioassay results showed they are less active than taxol. The molecular modeling studies suggested that the cyclopropyl-containing taxol analogs could not adopt the T-taxol conformation, which would result in the loss of bioactivities. It is an indirect evidence to support T-taxol conformation. As for macrocyclic taxol lactones, it is proposed that they would have a close contact between the ester moiety on the C-3' phenyl ring and Phe272 of the β-tubulin protein when they adopt T-taxol conformation. It will push the macrocyclics out of the binding pocket and lead to the lost of bioactivities.
Collections
- Doctoral Dissertations [14863]
Related items
Showing items related by title, author, creator and subject.
-
Method for the conversion of cephalomannine to taxol and for the preparation of n-acyl analogs of taxol
Chemistry; Center for Drug Discovery; Virginia Polytechnic Institute and State University; Kingston, David G. I.; Molinero, Anthony A.; Gunatilaka, A. Leslie (United States Patent and Trademark Office, 1995-11-28)The natural product cephalomannine can be converted to the important anticancer natural product taxol by a simple process involving the steps of dihydroxylation to give cephalomannine-diols, diol cleavage, benzoylation at ... -
Rearranged taxol compounds and method of using in testing of in vivo activity
Virginia Tech Intellectual Properties, Inc.; Kingston, David G. I.; Samaranayake, Gamini S. (United States Patent and Trademark Office, 1993-03-16)In a preferred embodiment, taxol is treated with mesyl chloride to prepare a taxol derivative with a contracted A-ring, which has comparable activity to taxol in a tubulin depolymerization assay, and which shows cytotoxicity ... -
Rearranged taxol compounds and method of using in testing of in vivo activity
Virginia Tech Intellectual Properties, Inc.; Kingston, David G. I.; Samaranayake, Gamini S. (United States Patent and Trademark Office, 1994-03-22)In a preferred embodiment, taxol is treated with mesyl chloride to prepare a taxol derivative with a contracted A-ring, which has comparable activity to taxol in a tubulin depolymerization assay, and which shows cytotoxicity ...